IDEAYA Biosciences (IDYA) Change in Cash (2018 - 2026)

IDEAYA Biosciences has disclosed Change in Cash across 9 years of filings, most recently posting $45.0 million for Q1 2026.

• Change in Cash for Q1 2026 came in at $45.0 million, down 1.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.0 million (up 29.05% YoY), and the FY2025 annual result was $28.7 million, up 139.48% from the prior year.
• Change in Cash came in at $45.0 million for Q1 2026 at IDEAYA Biosciences, up from -$185.9 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $217.2 million in Q3 2024 to a low of -$316.0 million in Q4 2024.
• The 5-year median for Change in Cash is $5.2 million (2023), against an average of $3.9 million.
• Across the five-year window, Change in Cash soared 685.64% in 2023 and tumbled 6173.63% in 2024, its largest moves.
• IDEAYA Biosciences' Change in Cash stood at -$33.3 million in 2022, then jumped by 115.61% to $5.2 million in 2023, then sank by 6173.63% to -$316.0 million in 2024, then surged by 41.18% to -$185.9 million in 2025, then surged by 124.19% to $45.0 million in 2026.
• The last three Change in Cash figures came in at $45.0 million (Q1 2026), -$185.9 million (Q4 2025), and $184.3 million (Q3 2025), per Business Quant data.